Tudor Investment Corp’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,347
| Closed | -$57.1K | – | 1768 |
|
|
2025
Q1 | $57.1K | Hold |
10,347
| – | – | ﹤0.01% | 1451 |
|
|
2024
Q4 | $59.5K | Sell |
10,347
-2
| -0% | -$11 | ﹤0.01% | 1453 |
|
|
2024
Q3 | $107K | Buy |
+10,349
| New | +$107K | ﹤0.01% | 1454 |
|
|
2024
Q2 | – | Sell |
-10,405
| Closed | -$182K | – | 1635 |
|
|
2024
Q1 | $182K | Buy |
+10,405
| New | +$182K | ﹤0.01% | 1334 |
|
|
2023
Q3 | – | Sell |
-10,365
| Closed | -$222K | – | 1611 |
|
|
2023
Q2 | $222K | Buy |
+10,365
| New | +$222K | ﹤0.01% | 1342 |
|
|
2022
Q4 | – | Sell |
-10,327
| Closed | -$536K | – | 1671 |
|
|
2022
Q3 | $536K | Sell |
10,327
-1,659
| -14% | -$86.1K | 0.01% | 1074 |
|
|
2022
Q2 | $567K | Sell |
11,986
-17,268
| -59% | -$817K | 0.01% | 1043 |
|
|
2022
Q1 | $2.08M | Buy |
29,254
+2,308
| +9% | +$164K | 0.05% | 519 |
|
|
2021
Q4 | $2.02M | Buy |
26,946
+19,049
| +241% | +$1.42M | 0.03% | 579 |
|
|
2021
Q3 | $449K | Sell |
7,897
-43,479
| -85% | -$2.47M | 0.01% | 1178 |
|
|
2021
Q2 | $2.26M | Buy |
51,376
+31,365
| +157% | +$1.38M | 0.04% | 485 |
|
|
2021
Q1 | $987K | Sell |
20,011
-24,075
| -55% | -$1.19M | 0.02% | 832 |
|
|
2020
Q4 | $1.86M | Buy |
+44,086
| New | +$1.86M | 0.05% | 438 |
|
|
2020
Q3 | – | Sell |
-11,227
| Closed | -$564K | – | 1341 |
|
|
2020
Q2 | $564K | Buy |
+11,227
| New | +$564K | 0.03% | 673 |
|
|
2017
Q3 | – | Sell |
-5,802
| Closed | -$209K | – | 1113 |
|
|
2017
Q2 | $209K | Sell |
5,802
-6,100
| -51% | -$220K | 0.01% | 864 |
|
|
2017
Q1 | $367K | Sell |
11,902
-3,568
| -23% | -$110K | 0.01% | 868 |
|
|
2016
Q4 | $518K | Buy |
+15,470
| New | +$518K | 0.01% | 685 |
|
|
2015
Q2 | – | Sell |
-9,800
| Closed | -$300K | – | 1490 |
|
|
2015
Q1 | $300K | Buy |
9,800
+813
| +9% | +$24.9K | 0.01% | 1036 |
|
|
2014
Q4 | $457K | Sell |
8,987
-11,609
| -56% | -$590K | 0.02% | 772 |
|
|
2014
Q3 | $815K | Buy |
+20,596
| New | +$815K | 0.03% | 373 |
|